3rd Quarter - Report

AVENUE SOLUTIONS for JAZZ PHARMACEUTICALS, INC.

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Drug safety issues; Monitor drug pricing legislation; Continue monitoring of Affordable Prescriptions for Patients Act of 2019 from 116th Congress; Continue monitoring of Affordable Prescriptions for Patients Through Promoting Competition Act of 2019 from 116th Congress; Continue monitoring of Elijah E. Cummings Lower Drug Costs Now Act from 116th Congress; Continue monitoring of Prescription Drug Pricing Reduction Act of 2019 from 116th Congress; Senate Finance Committee Prescription Drug Pricing Reform Principles; Implementation of American Rescue Plan Act of 2021 (PL 117-2) H.R. 5376, Build Back Better Act; Monitor Possible healthcare policies in upcoming reconciliation package including: making ACA tax credits/subsidies permanent, adding Medicare enhancements/supplemental benefits (hearing, dental, vision), addressing Medicaid coverage gap, expanding home and community based services, prescription drug reform; Proposed repeal of the CMS Rule on Most Favored Nation Model; Delay of the Rebate Rule

LobbyistCovered position, as disclosed
TRACY SPICER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5376 (117th)

Copyright/Patent/Trademark CPT

S. 1435, Affordable Prescriptions for Patients Act of 2021

LobbyistCovered position, as disclosed
TRACY SPICER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1435 (117th)

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.